Skip header and navigation

Refine By

2 records – page 1 of 1.

Source
Eur J Cancer Prev. 1995 Oct;4(5):389-417
Publication Type
Article
Date
Oct-1995
Author
F. Levi
C. La Vecchia
F. Lucchini
E. Negri
Author Affiliation
Institut Universitaire de Médecine Sociale et Préventive, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Source
Eur J Cancer Prev. 1995 Oct;4(5):389-417
Date
Oct-1995
Language
English
Publication Type
Article
Keywords
Breast Neoplasms - mortality
Death Certificates
Digestive System Neoplasms - mortality
Europe - epidemiology
Female
Gastrointestinal Neoplasms - mortality
Humans
Information Systems
Leukemia - mortality
Lung Neoplasms - mortality
Lymphoma - mortality
Male
Neoplasms - mortality
Research Support, Non-U.S. Gov't
Respiratory Tract Neoplasms - mortality
Sex Factors
Smoking - prevention & control
Stomach Neoplasms - mortality
Urogenital Neoplasms - mortality
World Health Organization
Abstract
Histograms of all age-standardized (world population) death certification rates for 23 cancers or groups of cancers for the period 1990-92 were produced for 35 countries of the European region (including a dozen new national entities) providing data to the World ealth Organization database. Substantial variations were observed in mortality from most common sites. For lung cancer the rate in males was 81/100,000 in Hungary, followed by Belgium, the Czech Republic, the Russian Federation and Poland, while in Sweden, Iceland and Norway, where comprehensive antismoking campaigns have been adopted over the last two decades, the rates were between 24 and 30 per 100,000 males. The lung cancer epidemic in European females is still in its early phases in most countries, with the sole exception of Scotland (29/100,000, ie the highest rates in the world), the rest of the UK, Denmark, Iceland, Ireland and Hungary. With reference to colorectal cancer, the highest rates were in the Czech Republic (38/100,000 males, 21/100,000 females) and other central European countries, and the lowest in Greece, Romania and a few Republics of the former Soviet Union, as well as Finland and Sweden. The highest gastric cancer mortality rates were in the Russian Federation (41/100,000 males, 18/100,000 females), followed by a few Republics of the former Soviet Union and Portugal in Western Europe. The highest breast cancer rates (25-29 per 100,000 females) were in the UK, Belgium, Ireland, The Netherlands, Denmark and other Scandinavian countries. For overall cancer mortality, the range of variation was between 260/100,000 in Hungary and 132/100,000 in Sweden for males, and between 142/100,000 in Denmark and 76/100,000 in Kyrgizstan for females, ie approximately a twofold variation in both sexes.
PubMed ID
7496328 View in PubMed
Less detail

Monitoring falls in gastric cancer mortality in Europe.

https://arctichealth.org/en/permalink/ahliterature181717
Source
Ann Oncol. 2004 Feb;15(2):338-45
Publication Type
Article
Date
Feb-2004
Author
F. Levi
F. Lucchini
J R Gonzalez
E. Fernandez
E. Negri
C. La Vecchia
Author Affiliation
Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut universitaire de médecine sociale et préventive, Lausanne, Switzerland. Fabio.Levi@inst.hospvd.ch
Source
Ann Oncol. 2004 Feb;15(2):338-45
Date
Feb-2004
Language
English
Publication Type
Article
Keywords
Adult
Death Certificates
Epidemiologic Studies
Europe - epidemiology
Female
Humans
Male
Middle Aged
Mortality - trends
Russia - epidemiology
Stomach Neoplasms - mortality
Abstract
We have considered trends in age-standardized mortality from gastric cancer in 25 individual European countries, as well as in the European Union (EU) as a whole, in six selected central-eastern European countries and in the Russian Federation over the period 1950-1999. Steady and persisting falls in rates were observed, and the fall between 1980 and 1999 was approximately 50% in the EU, 45% in eastern Europe and 40% in Russia. However, the declines were greater in Russia and eastern Europe, since rates were much higher, in absolute terms. Joinpoint regression analysis indicated that the falls were proportionally greater in the last decade for men (-3.83% per year in the EU) and in the last 25 years for women (-3.67% per year in the EU) than in previous calendar years. Moreover, steady declines in gastric cancer mortality were observed in the middle-aged and the young population as well, suggesting that they are likely to persist in the near future. In terms of number of deaths avoided, however, the impact of the decline in gastric cancer mortality will be smaller, particularly in the EU.
PubMed ID
14760131 View in PubMed
Less detail